Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Kidney Transplant III: Nursing Management

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.

Haematologica·2026

Same author

Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab.

Current oncology (Toronto, Ont.)·2026

Same author

Mantle cell lymphoma transformation to CD19-negative classic Hodgkin lymphoma as a novel mechanism of escape from CD19 chimeric antigen receptor T cell therapy.

Journal of hematopathology·2025

Same author

Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis.

Annals of hematology·2025

Same author

Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.

British journal of haematology·2025

Same author

Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AML.

Cells·2025

Search research articles

Related Experiment Video

Updated: Dec 1, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

[Transplant conditioning revisited].

Shin Mineishi¹

¹Blood and Marrow Transplant Program, Penn State Hershey Medical Center.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology

|November 9, 2020

Summary

Hematopoietic stem cell transplantation (HSCT) is evolving for acute leukemia, now integrated with targeted therapies. Efforts to reduce HSCT nonrelapse mortality allow comparisons with other curative options.

Area of Science:

Hematology
Oncology
Transplantation Medicine

Background:

Acute leukemia treatment has advanced significantly in the last decade.
Hematopoietic stem cell transplantation (HSCT) remains a critical, yet evolving, therapeutic modality.
Molecular-targeted therapies offer new curative options, altering HSCT's role.

Purpose of the Study:

To review the changing role of HSCT in acute leukemia treatment.
To discuss HSCT in aggressive leukemia and graft failure contexts.
To examine conditioning regimens for HSCT alongside targeted therapies.

Main Methods:

Literature review focusing on recent advancements in leukemia treatment.
Analysis of HSCT outcomes in aggressive leukemia and graft failure.

Keywords:

Acute leukemia Conditioning Nonrelapse mortality Stem cell transplant

More Related Videos

Orthotopic Hind Limb Transplantation in the Mouse

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

A Modified Method for Heterotopic Mouse Heart Transplantion

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

Related Experiment Videos

Last Updated: Dec 1, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Orthotopic Hind Limb Transplantation in the Mouse

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

A Modified Method for Heterotopic Mouse Heart Transplantion

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

Evaluation of conditioning regimens in the context of molecular-targeted therapy.

Main Results:

HSCT is increasingly integrated into comprehensive leukemia treatment plans.
Reduced nonrelapse mortality makes HSCT competitive with other modalities.
Targeted therapies are reshaping the landscape of HSCT indications and protocols.

Conclusions:

HSCT is a vital component of acute leukemia management, especially in aggressive forms.
The integration of targeted therapies necessitates updated HSCT strategies.
Further research on conditioning regimens is crucial for optimizing HSCT outcomes.